CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
200 g yogurt with fortified calcium content and MBP 80 mgdietary
Likely dose
200 g yogurt with fortified calcium content and MBP 80 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01501344
NCT01501344N/ACompleted

A 12-week, Open-label Study to Evaluate the Effect of MBP-80 (200g of Yogurt With Fortified Calcium Content and MBP 80 mg) on Bone Remodelling as Assessed by Bone Turnover Markers in Early Postmenopausal Women

Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc.·interventional·Posted Dec 29, 2011·Updated Jan 9, 2012

In Brief

A clinical study evaluating 200 g yogurt with fortified calcium content and MBP 80 mg for Postmenopausal Osteoporosis. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study will determine if daily oral intake of 200g of a marketed yogurt with fortified calcium content and a milk basic protein (MBP)80 mg benefits on bone cells activity in postmenopausal women. The efficacy of the product is measured by examining the variation of biochemical markers of bone turnover. MBP 80 is a particular protein contained in milk; it has been added to the yogurt provided for this study. The effects of MBP 80 on the quality of bone tissue have not yet been proven.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 29, 2011
Enrollment StartJan 1, 2011
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 14.5 years ago

Interventions

200 g yogurt with fortified calcium content and MBP 80 mgdietary

Intake of one container of vanilla or strawberry yogurt in the morning on a daily basis during 12 weeks.